Novel Mechanisms of Drug Action: Functional Selectivity at D2Dopamine Receptors
β Scribed by Richard B. Mailman; Elaine A. Gay
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 601 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1054-2523
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Seeman, P., D.E. Grigoriadis, and H.B. Niznik: Selectivity of agonists and antagonists at D2 dopamine receptors compared to D, and S2 receptors. Drug Dev. Res. 9:63-69, ## 1986. The common dopamine agonists (dopamine, apomorphine, ADTN, and N-propylnorapomorphine) are not selective for either D,
The properties of an (125)I-labeled structural analog of 2, 3-dimethoxy-N-[9-(4-fluorobenzyl)-9-azabicyclo[3.3. 1]nonan-3beta-yl]benzamide (MABN), (125)I-IABN, are described. (125)I-IABN was developed as a high-affinity radioligand selective for the D2-like (D2, D3, and D4) dopamine receptor subtype
The repeated administration of selective kappa-opioid receptor agonists prevents the locomotor activation produced by acute cocaine administration and the development of cocaine-induced behavioral sensitization. Previous studies have shown that dopamine (DA) D2 autoreceptors modulate the synthesis a
Tetracyclic Analogues of (+)-S 14297: Synthesis and Determination of Affinity and Selectivity at Cloned Human Dopamine D3 vs D2 Receptors. -Starting from the structure of the preferential D3 antagonist S 14297 a series of cis and trans tetracyclic derivatives are prepared following the routes depict